Poor adherence is a major concern in the treatment of attention-deficit/hyperactivity disorder
(ADHD). The objective of this study was to evaluate factors linked to early interruption of and
low adherence to treatment with osmotic-release oral system methylphenidate hydrochloride
(OROS-MPH) in pediatric patients with ADHD. A total of 1353 young people (age 6–17
years) with a diagnosis of ADHD who newly started OROS-MPH were extracted from the
pharmacoepidemiological data of 3 million people in Japan. The cohort was retrospectively …

CiNii 博士論文 - Risk factors for low adherence to methylphenidate treatment in pediatric
patients with attention-deficit/hyperactivity disorder … Risk factors for low adherence to
methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder
注意欠如・多動症の小児患者におけるメチルフェニデート塩酸塩治療のアドヒアランスを低下させる
因子について … Risk factors for low adherence to methylphenidate treatment in pediatric
patients with attention-deficit/hyperactivity disorder …